DATA GRAPHICS | Finance
IPO superstars
Back to School 2023: Six companies with NASDAQ IPOs since 2021 have more than doubled their market caps. Another four met the doubling mark via M&A
August 30, 2023 5:23 PM UTC
Six biopharma companies pricing IPOs on NASDAQ between the start of 2021 and the end of 1H23 have already seen their market capitalizations more than double, out of more than 154 IPOs on U.S. markets in that time. Four more have been acquired at prices more than twice their postmoney valuations.
The analysis sits alongside the Back to School 2023 essay, which focuses on building sustainable high-value biotechs, breaks down the landscape of public biotechs by market cap tier, and examines the criteria for jumping tier (see “Tier-jumpers: Building the road to sustainable biotechs”)...